Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: A systematic review and biomarker database integration

Human Reproduction

Volumn 30, Issue 1, 2015, Pages 133-148

  Khan, Gulafshana Hafeez ^a   Galazis, Nicolas ^a   Docheva, Nikolina ^a   Layfield, Robert ^a   Atiomo, William ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

biomarker; overlap; polycystic ovarian syndrome; pre eclampsia; proteomic

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN ALPHA CHAIN; FIBRINOGEN BETA CHAIN; FIBRINOGEN GAMMA CHAIN; LIPOCORTIN 2; PEROXIREDOXIN 2; TRANSFERRIN; UNCLASSIFIED DRUG; PROTEIN;

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PEPTIDE MAPPING; PERITONEAL BIOPSY; PLACENTA; PREECLAMPSIA; PROTEOMICS; RISK FACTOR; SYSTEMATIC REVIEW; COMPARATIVE STUDY; FEMALE; METABOLISM; PREGNANCY; RETROSPECTIVE STUDY;

BIOMARKERS; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PROTEINS; PROTEOMICS; RETROSPECTIVE STUDIES;

EID: 84922459966     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu268     Document Type: Article

References (54)

1. Altieri P, Gambineri A, Prontera O, Cionci G, Franchina M, Pasquali R. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 149:31-36
2. AnDerson NL, AnDerson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998;11:1853-1861
3. Atiomo WU, Khalid S, Ziauddin A, Tooth D, Layfield R. Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. Special Report. Expert Rev Proteomics 2009;6:469-499
4. Baek KH, Kim YS, Gu BH, Kim MS, Chung HY, Choi BC. Apolipoprotein as a novel gene associated with polycystic ovary syndrome. Annual Meeting of the American Society for Reproductive Medicine, ASRM 2010 Denver, CO United States. Fertil Steril 2010;94(Suppl. 1):S197-S198
5. Blankley RT, Gaskell SJ, Whetton AD, Dive C, Baker PN, Myers JE. A proof-ofprinciple gel-free proteomics strategy for the iDentification of predictive biomarkers for the onset of pre-eclampsia. BJOG 2009;116:1473-1480
6. Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, McCowan LM, Cooper GJ, North RA. A proteomic approach iDentifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics 2009a;9:2929-2945
7. BlumensteinM, Prakash R, Cooper GJ, North RA. SCOPEConsotrium.Aberrant processing of plasmavitronectin andhigh-molecular-weight kininogen preceDes the onset of preeclampsia. Reprod Sci 2009b;16:1144-1152
8. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-Analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-683
9. Buhimschi IA, Zhao G, Funai EF, Harris N, Sasson IE, Berstein IM, SaaDe GR, Buhimschi CS. Proteomic profiling of urine iDentifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.AmJ Obstet Gynecol 2008;199:551.e1-16
10. Burton GJ, Jauniaux E. Placental oxidative stress from miscarriage to preeclampsia. J Soc Gynecol Investig 2004;11:342-345
11. Centlow M, Hansson SR, WelinDer C. Differential proteome analysis of the preeclamptic placenta using optimized protein extraction. J Biomed Biotechnol 2010;2010. doi:10.1155/2010/458748
12. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers Lives: reviewing maternal Deaths to make motherhood safer: 2006-08. The Eighth Report on ConfiDential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl. 1):1-203
13. Cubedo J, Ramaiola I, Padro T, Martin-Yuste V, Sabate-Tenas M, Badimon L. High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with De novo acute myocardial infarction. Thromb Haemost 2013; 110:1121-1134
14. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
15. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401-419
16. EDelman MJ, Feliciano J, Yue B, Bejarano P, Ioffe O, Reisman D, Hawkins D, Gai Q, Hicks D, Serrero G. GP88 (progranulin): a novel tissue and circulatingbiomarker for non-small cell lung carcinoma. Hum Pathol 2014;45:1893-1899
17. Epiney M, Ribaux P, Arboit P, Irion O, Cohen M. Comparative analysis of secreted proteins from normal and preeclamptic trophoblastic cells using proteomic approaches. J Proteomics 2012;75:1771-1777
18. Galazis N, Docheva N, NicolaiDes KH, Atiomo W. Potential biomarkers for predicting preterm birth in women with polycystic ovary syndrome. Hum Reprod Update 2013;19:603
19. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY. Transferrin receptors in human tissues: their distribution and possible clinical releVance. J Clin Pathol 1983;36:539-545
20. Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E. Proteome differences of placenta between pre-eclampsia and normal pregnancy. Placenta 2010; 31:121-125
21. Gugliucci A, Ghitescu L. Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients. Med Hypotheses 2002;59:247-251
22. Hojlund K, Mogensen M, Sahlin K. Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinol Metab Clin North Am 2008;37:713
23. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics 2006;6:6326-6353
24. Huang J, Hsia SH, Imamura T, Usui I, Olefsky JM. Annexin II is a thiazolidinedione responsive gene involved in insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Endocrinology 2004;145:1579-1586
25. Jin H, Ma KD, Hu R, Chen Y, Yang J, Li XT, Yang PY. Analysis of expression and comparative profile of normal placental tissue proteins and those in preeclampsia patients using proteomic approaches. Anal Chim Acta 2008;629:158-164
26. Johnstone ED, Sawicki G, Guilbert L, Winkler-Lowen B, CaDete VJ, Morrish DW. Differential proteomic analysis of highly purified placental cytotrophoblasts in pre-eclampsia Demonstrates a state of increased oxidative stress and reduced cytotrophoblast antioxidant Defense. Proteomics 2011;11:4077-4084
27. Kang HM, Choi KS, Kassam G, Fitzpatrick SL, Kwon M, Waisman DM. Role of annexin II tetramer in plasminogen activation. Trends Cardiovasc Med 1999; 9:92-102
28. Kawano Y, Narahara H, Miyamura K, Mifune K, Miyakawa I. Inhibitory effect of transferrin on progesterone production in the granulosa cell of humans in vivo and porcine granulosa cell in vitro. Gynecol Obstet Invest 1995; 40:1-4
29. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011; 204:558.e1-6
30. Kolla V, Jeno P, Moes S, Lapaire O, Hoesli I, Hahn S.Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol 2012;2012:305964
31. Kralova A, Svetlikova M, Madar J, Ulcova-Gallova Z, Bukovsky A, Peknicova J. Differential transferrin expression in placentae from normal and abnormal pregnancies: a pilot study. Reprod Biol Endocrinol 2008;6:27
32. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003;278:50466-50473
33. Ling J, Zhao KK, Cui YG, Li Y, Wang X, Li M, Xue K, Ma X, Liu JY. Heat shock protein 10 regulated apoptosis of mouse ovarian granulosa cells. Gynecol Endocrinol 2011;27:63-71
34. Liu C, Zhang N, Yu H, Chen Y, Liang Y, Deng H, Zhang Z. Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta 2011;32:168-174
35. Ma X, Fan L, Hou Z, Mao YD, WangW, DingW, Liu JY. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Mol Hum Reprod 2007;13:527-523
36. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001; 16:226-229
37. Myers JE, Tuytten R, Thomas G, Laroy W, Kas K, Vanpoucke G, Roberts CT, Kenny LC, Simpson NA, Baker PN et al. Integrated Proteomics pipeline yields novel biomarkers for predicting preeclampsia. Hypertension 2013; 61:1281-1288
38. Park JS, Oh KJ, Norwitz ER, Hans JS, Choi HJ, Seong HS, Kang YD, ParkCW, Kim BJ, Jun JK et al. IDentification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod Sci 2008; 15:457-468
39. Parker LA, Gomez Saez N, Lumbreras B, Porta M, HernanDez-Aguado I. Methodological Deficits in diagnostic research using -omics technologies: evaluation of the QUADOMICS tool and quality of recently published studies. PLoS One 2010;5:e11419
40. Peral B, Camafeita E, FernanDez-Real JM. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Expert Rev Proteomics 2009;6:353-361
41. Rasanen J, Girsen A, Lu X, Lapidus JA, Standley M, Reddy A, Dasari S, Thomas A, Jacob T, Poula A et al. Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. J Proteome Res 2010;9:4274-4281
42. Redman CW. Preeclampsia: a multi-stress disorDer. Rev Med Interne 2011; 32(Suppl. 1):S41-S44
43. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47
44. Royal College of Obstetricians and Gynaecologists (2006) Management of Severe Pre-eclampsia and Eclampsia.
45. Solomon C, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am 2006;35:157-171
46. Szarka A, Rigo J Jr, Lazar L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia Determined by multiplex suspension array. BMC Immunol 2010;11:59
47. Tousoulis D, Andreou I, AntoniaDes C, Tentolouris C, Stefanadis C. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008;201:236-247
48. Treska V, Topolcan O. Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms. Int Angiol 2000; 19:64-68
49. Troisi R, Potischman N, Johnson CN, Roberts JM, Lykins D, Harger G, Markovic N, Siiteri P, Hoover RN. Estrogen and androgen concentrations are not lower in the umbilical cord serum of pre-eclamptic pregnancies. Cancer EpiDemiol Biomarkers Prev 2003;12(11 Pt 1):1268-1270
50. Vascotto C, Salzano AM, DAmbrosio C, Fruscalzo A, Marchesoni D, di Loreto C, Scaloni A, Tell G, Quadrifoglio F. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007; 6:160-170
51. Watanabe H, Hamada H, Yamada N, Sohda S, Yamakawa-Kobayashi K, Yoshikawa H, Arinami T. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics 2004;4:537-543
52. Wild RA. Long term health consequences of PCOS. Hum Reprod Update 2002;8:231-241
53. Wong MK, Takei Y. Lack of plasma kallikrein-kinin system cascaDe in teleosts. PLoS One 2013;8:e81057
54. Yun SH, Moon YS, Sohn SH, Jang IS. Effects of cyclic heat stress or vitamin C supplementation during cyclic heat stress on HSP70, inflammatory cytokines, and the antioxidant Defense system in Sprague Dawley rats. Exp Anim 2012;61:543-553